Forest, Almirall Drug Wins Backing of FDA Panel Advisers – Businessweek

The panel voted 12-2 today to recommend approval of aclidinium bromide, a twice-daily medication that reduces complications stemming from chronic obstructive pulmonary disease. The condition, typically caused by smoking, affects 12 million …

Leave a Reply

Your email address will not be published. Required fields are marked *